文献速递免疫规划妇幼与学校卫生

呼吸道合胞病毒对年长儿童的影响:探索2岁以上儿童预防策略的潜力

Impact of respiratory syncytial virus on older children: Exploring the potential for preventive strategies beyond the age of 2 years.
PubMed 文献 · Vaccine · 2024-07-29

该回顾性观察研究分析了Meyer儿童医院2019年10月至2023年3月期间28天至18岁呼吸道合胞病毒感染住院患儿的数据,比较2岁以下与2岁及以上两组疾病的严重程度指标和患者特征。结果显示,年长儿童合并症比例(41% vs 9%,p=0.000)和早产率(26% vs 14%,p=0.001)均高于2岁以下儿童。作者认为,当前预防措施忽视了2岁以上且伴有早产或合并症儿童的重症呼吸道合胞病毒下呼吸道感染风险,需开展前瞻性研究和成本效果分析以确定针对性免疫的必要性。

要点

  • 2岁以上呼吸道合胞病毒住院儿童合并症比例(41%)和早产率(26%)高于2岁以下儿童。
  • 流行季节2岁以上儿童住院人数上升。
  • 作者建议对具有特定风险因素的年长儿童开展前瞻性研究和成本效果分析。

核心结论

  • 研究强调,2岁以上且伴有早产或合并症的儿童发生重症呼吸道合胞病毒下呼吸道感染的风险增加,而当前预防措施忽视了这一群体。
  • 作者认为,需开展前瞻性研究和成本效果分析,以确定对具有特定风险因素的年长儿童进行针对性免疫的必要性,从而降低呼吸道合胞病毒相关发病率和死亡率。

研究设计与样本

  • 在Meyer儿童医院开展的观察性回顾性研究,分析2019年10月至2023年3月期间28天至18岁呼吸道合胞病毒感染患者的数据。
  • 比较2岁以下与2岁及以上两个年龄组的严重程度指标和患者特征。

主要发现

  • 共有584名婴幼儿因呼吸道合胞病毒感染住院。
  • 流行季节期间,2岁以上儿童住院人数上升。
  • 年长儿童合并症发生率高于2岁以下儿童(41% vs 9%,p=0.000)。
  • 年长儿童早产率高于2岁以下儿童(26% vs 14%,p=0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Respiratory syncytial virus (RSV) causes significant lower respiratory tract infections (LRTIs) in infants and young children. Current prevention targets those under 2 years. This study aims to evaluate RSV patterns and severity in children older than 2 years and to explore the potential extension of preventive strategies to this demographic group. METHODS: An observational retrospective study at Meyer Children's Hospital (from October 2019 to March 2023) analyzed data from patients between 28 days and 18 years of age with RSV infection. Severity indicators and patient characteristics were compared between two age groups: under 2 years and 2 years and above. RESULTS: 584 infants and young children were hospitalized due to RSV infection. Epidemic seasons saw a rise in hospitalizations among children older than 2 years. Older children had higher comorbidity (41% versus 9% p=0.000) and prematurity (26% versus 14% p = 0.001) rates than those under 2 years. CONCLUSION: The study highlights the increased risk of severe RSV LRTIs in children older than 2 years and with prematurity or comorbidities, overlooked by current preventive measures. Prospective studies and cost-effectiveness analyses are needed to determine the necessity of targeted immunization for older children with specific risk factors, aiming to reduce RSV-related morbidity and mortality.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Guarnieri V, Macucci C, Mollo A, et al. Impact of respiratory syncytial virus on older children: Exploring the potential for preventive strategies beyond the age of 2 years. Vaccine. 2024. PMID: 39079812. doi:10.1016/j.vaccine.2024.126170

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。